PPSG
MDCO

Princeton Portfolio Strategies Group’s Medicines Co MDCO Stock Holding History

Princeton Portfolio Strategies Group’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-6,500
Closed -$241K – 174
2017
Q3 		$241K Buy
+6,500
New +$240K 0.07% 157

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
TBC
Three Bays Capital Boston, Massachusetts $848M AUM 7.41% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Princeton Portfolio Strategies Group's MDCO Position: Q4 2017 in Review

Princeton Portfolio Strategies Group sold out of Medicines Co (MDCO) in Q4 2017, closing a stake of 6,500 shares — an estimated $241K sold.

Princeton Portfolio Strategies Group first reported a position in MDCO in Q3 2017 and held it in 1 quarter. The position peaked at $241K in Q3 2017. 202 funds tracked by Wall St. Rank hold MDCO as of Q4 2017.

  • Princeton Portfolio Strategies Group reported no remaining Medicines Co position as of Q4 2017 after selling out during the quarter.
  • Princeton Portfolio Strategies Group sold 6,500 Medicines Co shares in Q4 2017, an estimated $241K.
  • Princeton Portfolio Strategies Group first reported a position in Medicines Co in Q3 2017 and held it in 1 quarter.
  • Princeton Portfolio Strategies Group's Medicines Co position peaked at $241K in Q3 2017.
  • 202 funds tracked by Wall St. Rank held Medicines Co as of Q4 2017.

Based on Princeton Portfolio Strategies Group's 13F filing for Q4 2017, filed 12 Feb 2018.